Abiopharma

Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

Madison Square Garden Sports Corp. to Release Fiscal 2026 Third Quarter Results

Ultralife Corporation to Report First Quarter Results on May 8, 2026

Funko Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Director STEELE SALLY A 🟡 adjusted position in 0 shares (1 derivative) of COMMUNITY FINANCIAL SYSTEM, INC. (CBU) Transaction Date: Apr 29, 2026 | Filing ID: 000091

Director Wilson Darryl L. 🟡 adjusted position in 0 shares (1 derivative) of Solventum Corp (SOLV) Transaction Date: Apr 30, 2026 | Filing ID: 000006

📋 TUCHMAN MARTIN (Director) plans to sell 144K shares of FTAI Aviation Ltd. (at $242.39 each, total $34.8M) Filed: May 01, 2026 | ID: 000055

Lowry Simon C 🟢 acquired 100.1K shares of Emergent BioSolutions Inc. (EBS) Transaction Date: Apr 29, 2026 | Filing ID: 000007

(99% Neutral) SHOALS TECHNOLOGIES GROUP, INC. (SHLS) Announces Regulatory Update

Director MAY KAREN J 🟡 adjusted position in 0 shares (1 derivative) of Solventum Corp (SOLV) Transaction Date: Apr 30, 2026 | Filing ID: 000005

(99% Neutral) WASHINGTON TRUST BANCORP INC (WASH) Announces Regulatory Update

(75% Positive) IQSTEL INC (IQST) Files Form 8-K